News
Quotient Sciences Increases Spray Drying Capabilities in the U.S.
Quotient Sciences, has invested in additional spray drying capabilities at its formulation development and clinical trial manufacturing facility in Garnet Valley, PA.
6 / 50 articles displayed
-
-
News
Quotient Sciences have made a number of submissions through the HRA/MHRA Combined Ways of Working Pilot
The HRA and MHRA have been exploring opportunities to improve the service being offered for the approval and ongoing management of Clinical Trials of Medicinal Products (CTIMPs) and launched a pilot to test an integrated process – the Combined Ways of Working Pilot.
-
News
Quotient Sciences Significantly Expands Formulation and Manufacturing in UK
Quotient Sciences, a leading drug development services organization, has significantly expanded its formulation development and clinical trial manufacturing operations at its Reading, U.K., facility. The program’s investment has tripled the site’s GMP capacity, added new equipment for solid oral dose manufacturing and significantly increased staffing levels.
-
Growth
Quotient Sciences Constructs State-of-the-Art Early-Phase Formulation and Manufacturing Facility in U.S.
Quotient Sciences, announces a significant expansion to its operations in the U.S. with the opening of a state-of-the-art, 45,000-square-foot facility located near Philadelphia, in Garnet Valley, Pa. The $15 million investment will create a center of excellence for early-phase formulation development and clinical trial manufacturing.
-
News
Quotient Sciences is delighted to be taking part in the MHRA / HRA Combined Ways of Working Pilot
We are delighted to be taking part in the MHRA / HRA Combined Ways of Working Pilot and on Friday 22 June 2018 made its first two pilot Phase I submissions.
-
News
Pharmaterials rebrands to Quotient Sciences
Quotient Sciences announces that it has completed the integration and rebrand of Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K.